Skip to main content
SpringerLink
Log in

Design, Synthesis, and Biological Evaluation of 1,4-Bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes as Potential Chk1 Inhibitors

  • Letters to the Editor
  • Published:
Russian Journal of General Chemistry Aims and scope Submit manuscript

Abstract

A series of 1,4-bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes were designed as inhibitors of checkpoint kinase 1 (Chk1), based on the structure‒activity relationships for known inhibitors through docking simulations. The docking results suggested that the title compounds were similar to known inhibitors in interaction with the catalytic site of Chk1. Twelve compounds were synthesized by a one-pot procedure from amines, dimethyl acetylenedicarboxylate, and glyoxal in water in the presence of catalytic amounts of γ-cyclodextrin. The inhibitory activities of the synthesized compounds were evaluated in vitro using EC9706 esophageal cancer cells. The results indicated that 1,4-bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes significantly inhibited Chk1 (IC50 10.45 μM).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kastan, M.B. and Bartek, J., Nature, 2004, vol. 432, p. 316.

    Article  CAS  Google Scholar 

  2. Dai, Y. and Grant, S., Clin. Cancer Res., 2010, vol. 16, p. 376.

    Article  CAS  Google Scholar 

  3. Chen, J.S., Lin, S.Y., Tso, W.L., Yeh, G.C., Lee, W.S., Tseng, H., Chen, L.C., and Ho, Y.S., Mol. Carcinogen, 2006, vol. 45, p. 461.

    Article  CAS  Google Scholar 

  4. Carrassa, L., Broggini, M., Erba, E., and Damia, G., Cell Cycle, 2004, vol. 3, p. 1175.

    Article  Google Scholar 

  5. Ling, H., Wen, L., Ji, X., Tang, Y., He, J., Tan, H., Xia, H., Zhou, J., and Su, Q., Braz. J. Med. Biol. Res., 2010, vol. 43, p. 271.

    Article  CAS  Google Scholar 

  6. Ambre, P.K., Pissurlenkar, R.R., Coutinho, E.C., and Iyer, R.P., Canadian J. Chem., 2012, vol. 90, p. 675.

    Article  CAS  Google Scholar 

  7. King, C., Diaz, H., Barnard, D., Barda, D., Clawson, D., Blosser, W., Cox, K., Guo, S., and Marshall, M., Invest. New Drug, 2014, vol. 32, p. 213.

    Article  CAS  Google Scholar 

  8. Dai, Y., Chen, S., Kmieciak, M., Zhou, L., Lin, H., Pei, X.-Y., and Grant, S., Mol. Cancer Therap., 2013, vol. 12, p. 878.

    Article  CAS  Google Scholar 

  9. Archie, N.T., Rendahl, K.G., Sheikh, T., Cheema, H., Aardalen, K., Embry, M., Ma, S., Moler, E.J., Ni, Z.J., and de Menezes, D.E.L, Clin. Cancer Res., 2007, vol. 13, p. 591.

    Article  Google Scholar 

  10. Eldebss, T.M., Gomha, S.M., Abdulla, M.M., and Arafa, R.K., Med. Chem. Commun., 2015, vol. 6, p. 852.

    Article  CAS  Google Scholar 

  11. Smaill, J.B., Lee, H.H., Palmer, B.D., Thompson, A.M., Squire, C.J., Baker, E.N., Booth, R.J., Kraker, A., Hook, K., and Denny, W.A., Bioorg. Med. Chem. Lett., 2008, vol. 18, p. 929.

    Article  CAS  Google Scholar 

  12. Zhao, B., Bower, M.J., McDevitt, P.J., Zhao, H., Davis, S.T., Johanson, K.O., Green, S.M., Concha, N.O., and Zhou, B.-B.S., J. Biol. Chem., 2002, vol. 277, p. 46609.

    Article  CAS  Google Scholar 

  13. Jackson, J.R., Gilmartin, A., Imburgia, C., Winkler, J.D., Marshall, L.A., and Roshak, A., Cancer Res., 2000, vol. 60, p. 566.

    CAS  Google Scholar 

  14. Gojo, I., Perl, A., Luger, S., Baer, M.R., Norsworthy, K.J., Bauer, K.S., Tidwell, M., Fleckinger, S., Carroll, M., and Sausville, E.A., Invest. New Drug, 2013, vol. 31, p. 1217.

    Article  CAS  Google Scholar 

  15. Kumar, R. and Lown, J.W., Eur. J. Med. Chem., 2005, vol. 40, p. 641.

    Article  CAS  Google Scholar 

  16. Van Heerden, L., Cloete, T.T., Breytenbach, J.W., de Kock, C., Smith, P.J., Breytenbach, J.C., and N’Da, D.D., Eur. J. Med. Chem., 2012, vol. 55, p. 335.

    Article  Google Scholar 

  17. Liu, Q., Song, X.-Q., and Yan, H., Acta Crystallograph. C, 2014, vol. 70, p. 965.

    Article  CAS  Google Scholar 

  18. Ma, Y.-C., Su, N., Shi, X.-J., Zhao, W., Ke, Y., Zi, X., Zhao, N.-M., Qin, Y.-H., Zhao, H.-W., and Liu, H.-M., Toxicol. Appl. Pharm., 2015, vol. 282, p. 227.

    Article  CAS  Google Scholar 

  19. Jackson, J.-R., Gilmartin, A., and Imburgia, C., Cancer Res., 2000, vol. 60, p. 566.

    CAS  Google Scholar 

  20. Sun, M.M., Sun, Y.S., Zhao, Z.H., and Zhang, M.Z., Zhonghua Shiyan Waike Zazhi, 2014, vol. 31, p. 1128.

    CAS  Google Scholar 

  21. Morris, G.M., Goodsell, D.S., and Halliday, R.S., J. Comput. Chem., 1998, vol. 19, p 1639.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Life Science and Bioengineering, Beijing University of Technology, Pingleyuan no. 100 of Chaoyang District, Beijing, 100124, China

    H. Ren, L. Sun & H. Yan

Authors
  1. H. Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Yan.

Additional information

The text was submitted by the authors in English.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ren, H., Sun, L. & Yan, H. Design, Synthesis, and Biological Evaluation of 1,4-Bis(2,3-dihydro-5-oxopyrrol-4-yl)-1,3-butadienes as Potential Chk1 Inhibitors. Russ J Gen Chem 87, 3029–3035 (2017). https://doi.org/10.1134/S1070363217120490

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1070363217120490

Keywords

Search

Navigation